Ignite Creation Date:
2024-05-05 @ 11:34 AM
Last Modification Date:
2024-10-26 @ 9:09 AM
Study NCT ID:
NCT00077870
Status:
COMPLETED
Last Update Posted:
2009-09-03
First Post:
2004-02-12
Brief Title:
A Study to Evaluate the Safety of Escalating Doses of Ocrelizumab in Subjects With Rheumatoid Arthritis
Sponsor:
Genentech Inc
Organization:
Genentech Inc
Key Dates - Follows AllAPIJSON File Order
Start Date:
2004-02
Start Date Type:
None
Primary Completion Date:
None
Primary Completion Date Type:
None
Completion Date:
2006-12
Completion Date Type:
ACTUAL
First Submit Date:
2004-02-12
First Submit QC Date:
February 13 2004
Study First Post Date:
2004-02-16
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2009-09-01
Last Update Post Date:
2009-09-03
Last Update Post Date Type:
ESTIMATED